Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: Unclassified
The risk profile of AMT has not been fully characterised. Insufficient scientific data is available to draw definitive conclusions.
Neurotoxicity
possible
The following substances carry an elevated risk of adverse interactions with AMT. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
combinations
Tryptamin-Klasse: besonders gefährlich in Kombination mit MAO-Hemmern (inkl. Harmalin aus Ayahuasca)
dosing
AMT: extrem lange Wirkdauer (12–24h) — volle 2 Tage freie Zeit einplanen
dosing
Niedrig einsteigen — Tryptamine variieren stark in Potenz, genaue Dosierung kritisch
setting
Tripsitter bei Erstkonsum obligatorisch
dosing
Nüchtern konsumieren — Essen verlangsamt und verändert Resorption
combinations
Keine Kombination mit Lithium (Krampfrisiko)
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.